Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA – Philadelphia magazine
Philadelphia magazine |
Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA
Philadelphia magazine There’s a greater chance now than ever before that the Food and Drug Administration’s first two approved gene therapies will both come from Philadelphia. This week, the FDA granted “priority review” status to Spark Therapeutics’ biologics license … |
R & D Magazine |
Building the Safe Genes Toolkit
R & D Magazine Such chemicals could propel the development of therapeutic applications of genome editors by limiting off-target effects or protect against future biological threats. The team will also construct synthetic genome editors for precision genome engineering. |
Phys.Org |
Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb |
Phys.Org |
Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb |
Medical Xpress |
Innate reaction of hematopoietic stem cells to severe infections
Medical Xpress Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide—that is, without signals from growth factors. This direct production of defensive cells damages … |